Expression of transforming growth factor-β receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells

Journal of Cellular Physiology

Volumn 176, Issue 2, 1998, Pages 424-434

  Ko, Yong ^a   Banerji, Sunandita S ^a   Liu, Yu ^a   Li, Wenhui ^a   Liang, Jiurong ^a   Soule, Herbert D ^b   Pauley, Robert J ^b   Willson, James K V ^c   Zborowska, Elizabeth ^c   Brattain, Michael G ^d  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CARCINOGENICITY; CELL STRAIN MCF 7; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION;

ADENOCARCINOMA; ANIMALS; BREAST NEOPLASMS; CARCINOGENICITY TESTS; FEMALE; FIBRONECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROMOTER REGIONS (GENETICS); RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS; TRIXIS;

EID: 0031874414     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199808)176:2<424::AID-JCP21>3.0.CO;2-1     Document Type: Article

References (71)

1. Arrick, B.A., Korc, M., and Derynck, R. (1990) Differential regulation of expression of three transforming growth factor β species in human breast cancer cell lines by estradiol. Cancer Res., 50:299-303.
2. Arteaga, C.L., Carty-Dugger, T., Moses, H.L., Hurd, S.D., and Pietenpol, J.A. (1993) Transforming growth factor β1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice. Cell Growth Differ., 4:193-201.
3. Arteaga, C.L., Tandon, A.K., Von Hoff, D.D., and Osborne, C.K. (1988) Transforming growth factor β: Potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res., 48:3898-3904.
4. Bae, H.W., Geiser, A.G., Kim, D.H., Chung, M.T., Burmester, J.K., Sporn, M.B., Roberts, A.B., and Kim, S.-J. (1995) Characterization of the promoter region of the human transforming growth factor-β type II receptor gene. J. Biol. Chem., 270:29460-29468.
5. Bradford, M.A. (1976) Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem., 72:248-254.
6. Brand, T., and Schneider, M. (1995) Inactive type II and type I receptors for TGFβ are dominant inhibitors of TGFβ-dependent transcription. J. Biol. Chem., 270:8274-8284.
7. Brattain, M.G., Howell, G., Sun, L.Z., and Willson, J.K.V. (1994) Growth factor balance and tumor progression. Curr. Opin. Oncol., 6:77-81.
8. Brattain, M.G., Ko, Y., Banerji, S.S., Wu, G., and Willson, J.K.V. (1996a) Defects of TGFβ receptor signaling in mammary cell tumorigenesis. J. Mammary Gland Biol. Neoplasia, 1:363-370.
9. Brattain, M.G., Markowits, S.D., and Willson, J.K.V. (1996b) The type II transforming growth factor-β receptor as a tumor-suppressor gene. Curr. Opin. Oncol., 8:49-53.
10. Butta, A., MacLennan, K., Flanders, K.C., Sacks, N.P.M., Smith, I., McKinna, A., Dowsett, M., Wakefield, L.M., Sporn, M.B., Baum, M., and Colletta, A.A. (1992) Induction of transforming growth factor β1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res., 52:4261-4264.
11. Capocasale, R.J., Lamb, R.J., Vonderheid, E.C., Fox, F.E., Rook, A.H., Nowell, P.C., and Moore, J.S. (1995) Reduced surface expression of transforming growth factor β receptor type II in mitogen-activated T cells from Sezary patients. Proc. Natl. Acad. Sci. USA, 92:5501-5505.
12. Chakrabarty, S., Jan, Y., Brattain, M.G., Tobon, A., and Varani, J. (1989) Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-β. Cancer Res., 49:2112-2117.
13. Chen, R.-H., Ebner, R., and Derynck, R. (1993) Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science, 260:1335-1338.
14. Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J., and Rutter, W.J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18:5294-5298.
15. Derynck, R., Lindquist, P.B., Lee, A., Wen, D., Tamm, J., Graycar, J.L., Rhee, L., Mason, A.J., Miller, D.A., Coffey, R.J. Moses, H.L., and Chen, E.Y. A new type of transforming growth factor-β, TGF-β3. EMBO J., 7:3737-3743.
16. Dickson, R.B., Bates, S.E., McManaway, M.E., and Lippman, M.E. (1986) Characterization of estrogen responsive transforming activity in human breast cancer cell lines. Cancer Res., 46:1707-1713.
17. Dubois, V., Couissi, D., Schonne, E., Remacle, C., and Trouet, A. (1995) Intracellular levels and secretion of insulin-like growth factor binding proteins in MCF-7/6, MCF-7/AZ and MDA-MB-231 breast cancer cells: Differential modulation by estrogens in serum-free medium. Eur. J. Biochem., 232:47-53.
18. Ebner, R., Chen, R.-H., Shum, L., Lawler, S., Zioncheck, T.F., Lee, A., Lopez, A.R., and Derynck, R. (1993) Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science, 260:1344-1348.
19. Geiser, A.G., Burmester, J.K., Webbink, R., Roberts, A.B., and Sporn, M.B. (1992) Inhibition of growth by transforming growth factor-β following fusion of two nonresponsive human carcinoma cell lines. J. Biol. Chem., 267:2588-2593.
20. Gentry, L.E., Lioubin, M.N., Purchio, A.F., and Marquardt, H. (1988) Molecular events in the processing of recombinant pre-pro-transforming growth factor beta-1 to the mature polypeptide. Mol. Cell. Biol., 8:4162-4168.
21. Gill, P.G., Tilley, W.D., de Young, N.J., Lensink, I.L., Dixon, P.D., and Horsfall, D.J. (1991) Inhibition of T47D human breast cancer cell growth by the synthetic progestin R5020: Effects of serum, estradiol, insulin, and EGF. Breast Cancer Res. Treat., 20:53-62.
22. Gillies, R.J., Didier, N., and Denton, M. (1986) Determination of cell number in monolayer cultures. Anal. Biochem., 159:109-113.
23. Gorman, C.M., Moffat, L.F., and Howard, B.H. (1982) Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol., 2:1044-1051.
24. Hebert, C.D., and Birnbaum, L.S. (1989) Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor β in human squamous carcinoma cell lines. Cancer Res., 49:3196-3202.
25. Herman, M.E., and Katzenellenbogen, B.S. (1994) Alterations in transforming growth factor-α and -β production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth. Cancer Res., 54:5867-5874.
26. Ignotz, R.A., Endo, T., and Massague, J. (1987) Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β. J. Biol. Chem., 262:6443-6446.
27. Inagaki, M., Moustakas, A., Lin, H.Y., Lodish, M.F., and Carr, B.I. (1993) Growth inhibition by transforming growth factor β (TGF-β) type I is restored in TGFβ-resistant hepatoma cells after expression of TGF-β receptor type II cDNA. Proc. Natl. Acad. Sci. USA, 90:5359-5363.
28. Ito, M., Yasui, W., Kyo, E., Yokozaki, H., Nakayama, H., Ito, H., and Tahara, E. (1992) Growth inhibition of transforming growth factor β on human gastric carcinoma cells: Receptor and postreceptor signaling. Cancer Res., 52:295-300.
29. Jeng, M.-H., Dijke, P., Iwata, K.K., and Jordan, V.C. (1993) Regulation of the levels of three transforming growth factor β mRNAs by estrogen and their effects on the proliferation of human breast cancer cells. Mol. Cell. Endocrinol., 97:115-123.
30. Kadin, M.E., Cavaille-Coll, M.W., Gertz, R., Massague, J., Cheifetz, S., and George, D. (1994) Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc. Natl. Acad. Sci. USA, 91:6002-6006.
31. Kadonaga, J.T., Carner, K.R., Masiarz, F.R., and Tjian, R. (1987) Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell, 51:1078-1090.
32. Kalkhoven, E., Roelen, B.A.J., de Winter, J.P., Mummery, C.L., van den Eijnden-van Raaij, A.J.M., van der Saag, P.T., and van der Burg, B. (1995) Resistance to transforming growth factor β and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ., 6:1151-1161.
33. Karey, K.P., and Sirbasku, D.A. (1988) Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17β-estradiol. Cancer Res., 48:4083-4092.
34. Kim, I.Y., Ahn, H.-J., Zelner, D.J., Shaw, J.W., Sensibar, J.A., Kim, J.-H., Kato, M., and Lee, C. (1996) Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res., 56:44-48.
35. Kimchi, A., Wang, X.-F., Weinberg, R.A., Cheifetz, S., and Massague, J. (1988) Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells. Science, 240:196-199.
36. Klijn, J.G.M., Berns, P.M.J.J., Bontenbal, M., and Foekens, J.A. (1993) Growth factors: Clinical implications in breast cancer. Ann. NY Acad. Sci., 698:85-101.
37. Knabbe, C., Lippman, M.E., Wakefield, L.M., Flanders, K.C., Kasid, A., Derynck, R., and Dickson, R.B. (1987) Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell, 48:417-428.
38. Lin, P., Liu, C., Tsao, M.-S., and Grisham, J.W. (1987) Inhibition of proliferation of cultured rat liver epithelial cells at specific cell cycle stages by transforming growth factor-β. Biochem. Biophys. Res. Commun., 143:26-30.
39. Lippman, M.E., Dickson, R.B., Gelmann, E.P., Rosen, N., Knabbe, C., Bates, S., Bronzert, D., Huff, K., and Kasid, A. (1987) Growth regulation of human breast carcinoma occurs through regulated growth factor secretion. J. Cell. Biochem., 35:1-16.
40. MacCallum, J., Bartlett, J.M.S., Thompson, A.M., Keen, J.C., Dixon, J.M., and Miller, W.R. (1994) Expression of transforming growth factor beta mRNA isoforms in human breast cancer. Br. J. Cancer, 69:1006-1009.
41. Manni, A., Wright, C., and Buck, H. (1991) Growth factor involvement in the multifunctional regulation of MCF-7 breast cancer cell growth in soft agar. Breast Cancer Res. Treat., 20:43-52.
42. Manning, A.M., Williams, A.C., Game, S.M., and Paraskeva, C. (1991) Differential sensitivity of human colonie adenoma and carcinoma cells to transforming growth factor β (TGF-β): Conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-β. Oncogene, 6:1471-1476.
43. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L.-Z., Lutterbaugh, J., Fan, R.S., Zborowska, E., Kinzler, K.W., Vogelstein, B., Brattain, M., and Willson, J.K.V. (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science, 268:1336-1338.
44. Mazars, P., Barboule, N., Balsin, V., Vidal, B., Ducommun, B., and Valette, A. (1995) Effects of TGF-β1 (transforming growth factor-β1) on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells. FEBS Lett., 362:295-300.
45. Miyazono, K., Dijke, P.T., Ichijo, H., and Heldin, C.-H. (1994) Receptors for transforming growth factor-β. Adv. Immunol., 55:181-220.
46. Mulder, K.M., and Brattain, M.G. (1989) Effects of growth stimulatory factors on mitogenicity and c-myc expression in poorly differentiated and well differentiated human colon carcinoma cells. Mol. Endocrinol., 3:1215-1222.
47. Okamoto, A., Jiang, W., Kin, S.-J., Spillare, E.A., Stoner, G.D., Weinstein, I.B., and Harris, C.C. (1994) Overexpression of human cyclin D1 reduces the transforming growth factor β (TGF-β) type II receptor and growth inhibition by TGF-β1 in an immortalized human esophageal epithelial cell line. Proc. Natl. Acad. Sci. USA, 91:11576-11580.
48. Park, K.-C., Kim, S.-J., Bang, Y.-J., Park, J.-G., Kim, N.-K., Roberts, A.B., and Sporn, M.B. (1994) Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. USA, 91:8772-8776.
49. Periyasamy, S., Sun, L.-Z., Gentry, L.E., and Brattain, M.G. (1996) Differential control of expression of type I and type II receptors of transforming growth factor-β in colon carcinoma cells. J. Cell. Physiol., 168:711-720.
50. Pratt, S.E., and Pollak, M.N. (1993) Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media. Cancer Res., 53:5193-5198.
51. Pugh, B.F., and Tjian, R. (1990) Mechanism of transcriptional activation by Sp1: Evidence for coactivators. Cell, 61:1187-1197.
52. Pugh, B.F., and Tjian, R. (1991) Transcription from a TATA-less promoter requires a multisubunit TFIID complex. Genes Dev., 5:1935-1945.
53. Reddy, K.B., Yee, D., Hilsenbeck, S.G., Coffey, R.J., and Osborne, C.K. (1994) Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor-α expression. Cell Growth Differ., 5:1275-1282.
54. Roberts, A.B., Anzano, M.A., Wakefield, L.M., Roche, N.S., Stern, D.F., and Sporn, M.B. (1985) Type β transforming growth factor: A bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA, 82:119-123.
55. Rosenthal, N. (1987) Identification of regulatory elements of cloned genes with functional assays. Methods Enzymol., 152:704-720.
56. Ruff, E., and Rizzino, A. (1986) Preparation and binding of radioactively labeled porcine transforming growth factor type β. Biochem. Biophys. Res. Commun., 138:714-719.
57. Soule, H.D., Vazguez, J., Long, A., Albert, S., and Brennan, M. (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst., 51:1409-1416.
58. Sun, L.-Z., Wu, G., Willson, J.K.V., Zborowska, E., Yang, J., Rajkarunanayake, I., Wang, J., Gentry, L.E., Wang, X.-F., and Brattain, M.G. (1994) Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J. Biol. Chem., 269:26449-26455.
59. Vignon, F. (1989) Steroid hormones and breast cancer: Relation with hormone-regulated growth factors and oncogenes. Growth Factors Oncogenes, 190:75-86.
60. Vivien, D., Attisano, L., Wrana, J.L., and Massague, J. (1995) Signaling activity of homologous and heterologous transforming growth factor-β receptor kinase complex. J. Biol. Chem., 270:7134-7141.
61. Wang, J., Sun, L.-Z., Myeroff, L., Wang, X.-F., Gentry, L.E., Yang, J., Liang, J., Zborowska, E., Markowitz, S., Willson, J.K.V., and Brattain, M.G. (1995) Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem., 270:22044-22049.
62. Wang, J., Han, W., Zborowska, E., Liang, J., Wang, X., Willson, J.K.V., Sun, L.-Z., and Brattain, M.G. (1996) Reduced expression of transforming growth factor β type I receptor contributes to the malignancy of human colon carcinoma cells. J. Biol. Chem., 271:17366-17371.
63. Wrana, J.L., Attisano, L., Wieser, R., Ventura, F., and Massague, J. (1994) Mechanism of activation of the TGF-β receptor. Nature, 370:341-347.
64. Wu, S.-P., Theodorescu, D., Kerbel, R.S., Willson, J.K.V., Mulder K.M., Humphrey, L.E., and Brattain, M.G. (1992) TGF-β1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J. Cell Biol., 116:187-196.
65. Wu, S.-P., Sun, L.-Z., Willson, J.K.V., Humphrey, L., Kerbel, R., and Brattain, M.G. (1993) Repression of autocrine transforming growth factor β1 and β2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties. Cell Growth Differ., 4:115-123.
66. Yamada, N., Kato, M., Yamashita, H., Nister, M., Miyazono, K., Heldin, C.-H., and Funa, K. (1995) Enhanced expression of transforming growth factor-β and its type-I and type-II receptors in human glioblastoma. Int. J. Cancer, 62:386-392.
67. Yamashita, H., Dijke, P.T., Franzen, P., Miyazono, K., and Heldin, C.-H. (1994) Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J. Biol. Chem., 269:20172-20178.
68. Yingling, J.M., Wang, X.-F., and Bassing, C.H. (1995) Signaling by the transforming growth factor-β receptors. Biochim. Biophys. Acta, 1242:115-136.
69. Zhao, Y., and Young, S.L. (1996) Requirement of transforming growth factor-β (TGF-β) type II receptor for TGF-β-induced proliferation and growth inhibition. J. Biol. Chem., 271:2369-2372.
70. Zhou, G.-H., Sechrist, G.L., Periyasamy, S.P., Brattain, M.G., and Mulder, K.M. (1995) Transforming growth factor β isoform-specific differences in interactions with type I and II transforming growth factor β receptors. Cancer Res., 55:2056-2062.
71. Zugmaier, G., Ennis, B.W., Deschauer, B., Datz, D., Knabbe, C., Wilding, G., Daly, P., Lippman, M.E., and Dickson, R.B. (1989) Transforming growth factors type β1 and β2 are equipotent growth inhibitors of human breast cancer cell lines. J. Cell. Physiol., 141:353-361.